We are live on ! Find out more
CF

CNA Financial Portfolio holdings

AUM $235M
1-Year Est. Return 3.39%
This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+3.39%
3 Year Est. Return
+50.54%
5 Year Est. Return
+66.93%
10 Year Est. Return
+254.04%
AUM
$322M
AUM Growth
-$60.2M
Cap. Flow
-$22.2M
Cap. Flow %
-6.9%
Top 10 Hldgs %
31.34%
Holding
203
New
11
Increased
51
Reduced
71
Closed
16

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$6.75M
2
LNG icon
Cheniere Energy
LNG
+$6.08M
3
HBI
Hanesbrands
HBI
+$4.72M
4
META icon
Meta Platforms (Facebook)
META
+$4.5M
5
GM icon
General Motors
GM
+$4.49M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.86M
2
CSGP icon
CoStar Group
CSGP
+$7.11M
3
CME icon
CME Group
CME
+$6.17M
4
J icon
Jacobs Solutions
J
+$5.57M
5
JPM icon
JPMorgan Chase
JPM
+$4.75M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 19.56%
3 Consumer Discretionary 14.54%
4 Industrials 8.94%
5 Financials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSGS icon
151
Madison Square Garden
MSGS
$9.59B
$472K 0.15%
2,631
– –
FSR
152
DELISTED
Fisker Inc.
FSR
$467K 0.14%
36,190
+3,610
+11% +$45.2K
ACVA icon
153
ACV Auctions
ACVA
$1.41B
$465K 0.14%
+31,412
New +$437K
RLAY icon
154
Relay Therapeutics
RLAY
$4B
$465K 0.14%
15,549
-440
-3% -$10.7K
PAR icon
155
PAR Technology
PAR
$716M
$437K 0.14%
+10,840
New +$444K
LBRDK icon
156
Liberty Broadband Class C
LBRDK
$4.89B
$435K 0.13%
3,217
– –
FRPT icon
157
Freshpet
FRPT
$3.04B
$412K 0.13%
4,010
-800
-17% -$75.3K
ALTR
158
DELISTED
Altair Engineering Inc
ALTR
$406K 0.13%
6,311
– –
RARE icon
159
Ultragenyx Pharmaceutical
RARE
$2.46B
$402K 0.12%
5,530
-40
-0.7% -$2.78K
VIR icon
160
Vir Biotechnology
VIR
$1.46B
$400K 0.12%
15,542
+1,790
+13% +$53.1K
ASND icon
161
Ascendis Pharma A/S
ASND
$16.5B
$389K 0.12%
3,315
-251
-7% -$29.1K
BRZE icon
162
Braze
BRZE
$3.02B
$386K 0.12%
9,297
+700
+8% +$35.1K
CHRS icon
163
Coherus Oncology
CHRS
$217M
$377K 0.12%
29,191
-110
-0.4% -$1.4K
ZNTL icon
164
Zentalis Pharmaceuticals
ZNTL
$332M
$377K 0.12%
8,176
+220
+3% +$11.9K
LEGN icon
165
Legend Biotech
LEGN
$3.65B
$365K 0.11%
10,055
-290
-3% -$11.5K
GDYN icon
166
Grid Dynamics Holdings
GDYN
$569M
$360K 0.11%
25,595
-2,012
-7% -$41.1K
BHVN
167
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$356K 0.11%
3,000
-2,720
-48% -$339K
WIX icon
168
WIX.com
WIX
$2.56B
$343K 0.11%
3,285
-496
-13% -$54.1K
MXCT icon
169
MaxCyte
MXCT
$108M
$335K 0.1%
47,974
-11,929
-20% -$81.4K
ITOS
170
DELISTED
iTeos Therapeutics
ITOS
$324K 0.1%
10,055
-2,520
-20% -$91.6K
RPC
171
Ridgepost Capital
RPC
$926M
$322K 0.1%
26,608
– –
DKNG icon
172
DraftKings
DKNG
$12.2B
$303K 0.09%
15,567
-3,653
-19% -$77.6K
YMAB
173
DELISTED
Y-mAbs Therapeutics
YMAB
$302K 0.09%
25,450
+7,220
+40% +$74.1K
ENFN
174
DELISTED
Enfusion, Inc.
ENFN
$289K 0.09%
22,759
– –
VITL icon
175
Vital Farms
VITL
$586M
$268K 0.08%
21,697
– –
5 6
7
8 9

Similar funds

JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
CWL
Causey Wealth LLC Greenwood Village, Colorado $236M AUM 14.5% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
BWM
Bernard Wealth Management Royal Oak, Michigan $234M AUM 27.82% 1-Year Est. Return
GCM
Gables Capital Management Miami, Florida $236M AUM 32.91% 1-Year Est. Return
RP
Raelipskie Partnership Waterloo, Ontario, Canada $236M AUM 19.33% 1-Year Est. Return
KTM
Keeler Thomas Management Orem, Utah $236M AUM 10.79% 1-Year Est. Return
HWMT
Heritage Wealth Management (Texas) Houston, Texas $234M AUM 15.67% 1-Year Est. Return

CNA Financial's Q1 2022 Portfolio in Review

As of Q1 2022, CNA Financial held 203 positions worth $322M, down 16% from $383M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

CNA Financial withdrew a net $22.2M in Q1 2022, closing 16 positions and reducing 71 holdings. Its most notable exit was Pfizer, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, CNA Financial opened a new position in Morgan Stanley worth $6.12M.

  • CNA Financial's largest Q1 2022 buy was Morgan Stanley: 70,000 shares worth $6.12M.
  • CNA Financial added most to Meta Platforms (Facebook) in Q1 2022, an estimated $4.5M increase.
  • CNA Financial's biggest Q1 2022 reduction was CVS Health, cutting an estimated $3.68M.
  • CNA Financial fully exited Pfizer in Q1 2022, selling an estimated $8.86M.
  • CNA Financial's ten largest holdings make up 31% of its $322M portfolio in Q1 2022.
  • CNA Financial opened 11 new positions and closed 16 in Q1 2022.
  • CNA Financial's portfolio value fell 16% quarter-over-quarter to $322M.

Based on CNA Financial's 13F filing for Q1 2022, filed 10 May 2022.